Biocare Medical

Biocare Medical is at NCSH 2025 Annual Meeting! Join Travis Mullan and Vanessa Artman in Durham, NC, on February 28th - March 1st as they showcase Biocare's latest advancements in immunohistochemistry and diagnostic solutions. Visit our booth to explore cutting-edge staining instruments and learn how Biocare is shaping the future of histotechnology—fighting cancer one slide at a time. ?? Stop by, connect with our experts, and see innovation in action! #IHC #Histotechnology #CancerDiagnostics #NCSH2025

Biocare Medical is thrilled to be part of the NCSH 2025 Annual Meeting on February 28th and March 1st. Visit our booth to discover cutting-edge advancements in immunohistochemistry, featuring advanced staining instruments and diagnostic solutions. Please connect with our experts firsthand and learn how Biocare is shaping the future of histotechnology and fighting cancer one slide at a time. www.biocare.net

As we recognize Gall Bladder Cancer Awareness Month, it's crucial to shine a light on key markers that play pivotal roles in our understanding of this disease. SMAD4 is a DNA-binding protein that belongs to the SMAD family of transcription factors. Activated SMAD4 complexes may accumulate in the nucleus and act as mediators of TGF-β signal transduction. SMAD4 mutations or deletions may be linked to hereditary hemorrhagic telangiectasia syndrome, and juvenile polyposis syndrome. SMAD4 mutations or deletions have also been implicated in multiple cancer indications including cholangiocarcinoma, colorectal, head and neck, and pancreatic cancer. https://lnkd.in/g8y8ZYK Let's continue our collective efforts in research, awareness, and support to better understand, prevent, and treat Gall Bladder cancer. Knowledge is our best weapon. ????

Gall Bladder Cancer Awareness Month Spotlight: The role of CA 19-9 Antibody As we recognize Gall Bladder Cancer Awareness Month, it's crucial to shine a light on key markers that play pivotal roles in our understanding of this disease. CA 19-9 (carbohydrate antigen 19-9) is a tumor-associated antigen that is often used as a biomarker in the diagnosis and monitoring of certain cancers, particularly gastrointestinal cancers. Diagnostic utility: ? The CA 19-9 antibody has been shown to label adenocarcinomas of the pancreas, stomach, breast, colon and gall bladder. ? Studies show that CA 19-9 positive expression may be a predictor of increased cancer mortality. ? CA 19-9 is also expressed in primary and metastatic ovarian carcinomas. https://lnkd.in/gC4ymazw Let's continue our collective efforts in research, awareness, and support to better understand, prevent, and treat Gall Bladder cancer. Knowledge is our best weapon. ????

???Biocare is proud to partner with leading Contract Research Organizations (CROs) to drive innovation in advanced staining. Our partnerships ensure that our staining solutions, such as ONCORE Pro X, perform at a high level in high-throughput and specialized lab environments, advancing research and diagnostics. Explore our CRO lab collaborations and more at https://lnkd.in/gJbXX2aa

β- Catenin Gall Bladder Cancer Awareness Month Spotlight: The role of Mucin beta catenin As we recognize Gall Bladder Cancer Awareness Month, it's crucial to shine a light on key markers that play pivotal roles in our understanding of this disease. Beta-catenin is a component of the Wnt signaling pathway, which plays a crucial role in regulating cell adhesion, proliferation, and differentiation. Diagnostic utility: ? Studies have suggested that altered beta-catenin expression may be associated with the progression and aggressiveness of gallbladder cancer. ? High levels of nuclear beta-catenin expression may indicate a more invasive phenotype. ? Studies suggest it may be useful in the differential diagnosis of selected soft tissue tumors and tumors of the GI tract, pancreas, lung, and female genital tract. https://lnkd.in/gd3qJTkM Let's continue our collective efforts in research, awareness, and support to better understand, prevent, and treat Gall Bladder cancer. Knowledge is our best weapon. ????

We’re thrilled to invite you to visit Biocare Medical at USCAP 2025 as we unveil our latest portfolio innovation in advanced staining—Pro Automation, the new benchmark for precision and efficiency in laboratory staining systems. Explore how our new cutting-edge system transforms laboratory expectations of what “could be” to what “is”.?Superior staining and reproducibility. A robust platform that’s easy to use and improves workflows.?Experience firsthand this exciting opportunity for Biocare to do more - all while keeping our focus on the unparalleled quality and reliability that you’ve come to expect from Biocare. ?? Event: USCAP 2025 ?? Date: March 24-26 ?? Booth: 501 Don't miss this opportunity for a hands-on demonstration of our new IHC/ISH/FISH platform. Visit our booth and discover how Pro Automation can elevate your lab's performance.?Register for an in-person demonstration below We look forward to seeing you there! https://lnkd.in/gNXrHgFn

Gall Bladder Cancer Awareness Month Spotlight: The role of Mucin 5AC As we recognize Gall Bladder Cancer Awareness Month, it's crucial to shine a light on key markers that play pivotal roles in our understanding of this disease. Mucin 5AC antibody (MUC5AC) is defined as a secretory-type mucin and is seen mainly in gastric foveolar cells. Diagnostic utility: ? A study has suggested that MUC5AC expression is an early event in tumorigenesis. ? Other studies have shown varied expression patterns of MUC5AC in gallbladder cancer. Some research suggests that MUC5AC expression might be higher in certain subtypes of gallbladder tumors, such as papillary adenocarcinoma. ? Another study indicates up-regulation of MUC5AC may be associated with carcinogenesis, malignant potential, progression, and clinical behaviors in colorectal signet-ring cell carcinoma. https://lnkd.in/d2XdNAp6 Let's continue our collective efforts in research, awareness, and support to better understand, prevent, and treat Gall Bladder cancer. Knowledge is our best weapon. ????

Biocare Medical is showcasing our latest breakthrough—Pro Automation—at Medlab 2025! Join us at Booth Z3.D59 to see how our state-of-the-art platforms are redefining efficiency and precision in advanced staining. Discover firsthand how Pro Automation streamlines your lab workflow, delivers unparalleled staining quality, and sets a new standard for productivity. Our team will be on hand to provide live demonstrations, answer your questions, and discuss how our solutions can drive success in your lab. Don’t miss out on this opportunity to transform your diagnostic processes. We look forward to welcoming you at Medlab 2025!??Biocare Medical – Fighting Cancer One Slide at A Time. #medlabmiddleeast #medlab2025 #diagnostics #biocaremedical

?? Spotlight on Our D13S319/LAMP1/CON12 FISH Probe for CLL Research Understanding the genetic landscape of chronic lymphocytic leukemia (CLL) is essential for advancing research into disease mechanisms and potential therapeutic targets. Among the most well-documented chromosomal alterations in CLL are 13q deletions and trisomy 12, both of which have been widely studied for their role in disease progression. Our D13S319/LAMP1/CON12 FISH probe is a valuable tool for researchers investigating these key genomic changes, offering simultaneous detection of: ? D13S319 (13q14.2): A region frequently deleted in CLL. ? LAMP1 (13q34): A control probe to differentiate deletions from normal chromosomal variations. ? CON12: A centromeric probe for chromosome 12, useful in detecting trisomy 12. By targeting these critical regions, this tri-color FISH probe enables researchers to gain deeper insights into the genomic alterations associated with CLL, supporting further advancements in leukemia research. https://lnkd.in/gVnvqm9c #CLLResearch #Genomics #FISHProbe #Cytogenetics #EmpireGenomics ? Reference: Puiggros et al., Biomed Res Int 2014;1-13